Earlier this month, the Partnership for Safe Medicines (PSM) released the L.E.A.D.E.R.’s Guide for Pharmacists to encourage pharmacists to take an active role in protecting the supply chain from counterfeit drugs. This effort is one of many to help curb the distribution of harmful and potentially deadly counterfeit drugs. Similarly, the Royal Pharmaceutical Society of Great Britain (RPSGB), Medicines and Healthcare products Regulatory Agency (MHRA) and the Dispensing Doctor’s Association (DDA) issued Counterfeit medicines: Guidance for pharmacists, explaining the background of counterfeit drugs, their production and distribution to pharmacists.

[...]

In the past two weeks, the Partnership for Safe Medicines issued two SafeMeds Alerts about counterfeit insulin pen needles and herbal medication adulterated with dangerously high levels of undeclared pharmaceuticals in the United Kingdom. It is tempting to disregard these alerts since the drugs were found in England, not the United States. But in today’s global environment, we are all at risk when these unsafe products move through the drug supply chain undetected.

[...]